Literature DB >> 8123019

The effect of KN-62, Ca2+/calmodulin dependent protein kinase II inhibitor on cell cycle.

H Minami1, S Inoue, H Hidaka.   

Abstract

The isoquinolinesulfonamide derivative, KN-62, is a potent and specific inhibitor of Ca2+/calmodulin dependent protein kinase II (CaM kinase II) (Tokumitsu, H., Chijiwa, T., Hagiwara, M., Mizutani, A., Terasawa, M., and Hidaka, H.(1990) J. Biol. Chem. 265, 4315-4320). KN-62 inhibits growth of K562 cells, in a dose-dependent manner. Flow cytometric analysis demonstrates that the treatment of K562 cells with 10 microM KN-62 causes an accumulation of cells in S phase. Immunoblotting studies showed that specific antibodies against CaM kinase II recognized the 65 kDa of protein in K562 cells. This protein showed protein kinase activity as examined by the activity gel method. The inhibition of this enzyme activity by KN-62 was dose-dependent. The immunoprecipitates with the antibodies from K562 cells phosphorylates the synthetic peptide substrates, syntide-2. These results suggest that CaM kinase II plays an important role in the mechanisms for the cell growth in K562 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8123019     DOI: 10.1006/bbrc.1994.1220

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  CaMKII Inhibitor KN-62 Blunts Tumor Response to Hypoxia by Inhibiting HIF-1α in Hepatoma Cells.

Authors:  Kyoung-Hwa Lee
Journal:  Korean J Physiol Pharmacol       Date:  2010-10-31       Impact factor: 2.016

2.  SERCA activity is required for timely progression through G1/S.

Authors:  V R Simon; M F Moran
Journal:  Cell Prolif       Date:  2001-02       Impact factor: 6.831

3.  Ca(2+) calmodulin kinase and calcineurin mediate IGF-1-induced skeletal muscle dihydropyridine receptor alpha(1S) transcription.

Authors:  Z Zheng; Z M Wang; O Delbono
Journal:  J Membr Biol       Date:  2004-01-15       Impact factor: 1.843

4.  Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathway.

Authors:  Shenglin Ma; Yunshan Yang; Chunmei Wang; Ning Hui; Linhui Gu; Haijun Zhong; Zhijian Cai; Qingqing Wang; Qinghua Zhang; Nan Li; Xuetao Cao
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

5.  A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization.

Authors:  Chunmei Wang; Nan Li; Xingguang Liu; Yuanyuan Zheng; Xuetao Cao
Journal:  J Biol Chem       Date:  2008-02-27       Impact factor: 5.157

Review 6.  The dysregulated expression and functional effect of CaMK2 in cancer.

Authors:  Qi He; Zhenyu Li
Journal:  Cancer Cell Int       Date:  2021-06-30       Impact factor: 5.722

7.  The linkage between beta1 integrin and the actin cytoskeleton is differentially regulated by tyrosine and serine/threonine phosphorylation of beta1 integrin in normal and cancerous human breast cells.

Authors:  K Takahashi
Journal:  BMC Cell Biol       Date:  2001-11-08       Impact factor: 4.241

Review 8.  The emerging role of CaMKII in cancer.

Authors:  Yan-yang Wang; Ren Zhao; Hong Zhe
Journal:  Oncotarget       Date:  2015-05-20

9.  Calmodulin and Its Interactive Proteins Participate in Regulating the Explosive Growth of Alexandrium pacificum (Dinoflagellate).

Authors:  Yuan Liu; Zhimei Zhu; Zhenghong Sui; Haoxin Liu; Sadaf Riaz
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

Review 10.  Decoding the Phosphatase Code: Regulation of Cell Proliferation by Calcineurin.

Authors:  Takahiro Masaki; Midori Shimada
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.